Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
01 01 2021
Historique:
received: 07 10 2020
accepted: 12 11 2020
pubmed: 27 11 2020
medline: 20 4 2021
entrez: 26 11 2020
Statut: ppublish

Résumé

We previously demonstrated that angiopoietin-like 8 (ANGPTL8) forms a localized complex with ANGPTL4 to reduce its lipoprotein lipase (LPL)-inhibitory activity and enable increased postprandial uptake of fatty acids (FA) into adipose tissue. Because prolonged cold exposure may increase adipose tissue FA uptake and decrease circulating triglycerides (TG) by reducing ANGPTL4 expression and inducing ANGPTL8 expression (and thus ANGPTL4/8 expression), we investigated the effect of temperature on ANGPTL4 and ANGPTL4/8 LPL-inhibitory activities in vitro. As the ANGPTL4(E40K) mutation results in decreased TG, we also characterized ANGPTL4(E40K) and ANGPTL4(E40K)/8 complex LPL-inhibitory activities. Interestingly, while ANGPTL3, ANGPTL3/8, and ANGPTL4 showed similar LPL inhibition at 37 °C and 22 °C, the already reduced LPL-inhibitory activity of ANGPTL4/8 at 37 °C was even more decreased at 22 °C. At 37 °C, ANGPTL4(E40K) manifested decreased LPL-inhibitory activity compared to ANGPTL4/8, while ANGPTL4(E40K)/8 had even further reduced potency. Remarkably, ANGPTL4/8, ANGPTL4(E40K), and ANGPTL4(E40K)/8 were each actually capable of stimulating LPL activity at 22 °C. Together, these results indicate that ANGPTL4/8 stimulation of LPL activity at low temperatures may represent an additional mechanism for further increasing adipose tissue FA uptake during cold exposure, beyond that already occurring due to decreased ANGPTL4 expression and increased ANGPTL8 expression. In addition, because ANGPTL4(E40K) has decreased LPL-inhibitory activity compared to ANGPTL4/8, our findings also suggest why ANGPTL4(E40K) carriers have decreased circulating TG levels.

Identifiants

pubmed: 33239171
pii: S0006-291X(20)32098-2
doi: 10.1016/j.bbrc.2020.11.053
pii:
doi:

Substances chimiques

ANGPTL4 protein, human 0
ANGPTL8 protein, human 0
Angiopoietin-Like Protein 4 0
Angiopoietin-Like Protein 8 0
Angiopoietin-like Proteins 0
Peptide Hormones 0
Lipoprotein Lipase EC 3.1.1.34

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

498-503

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Yan Q Chen (YQ)

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.

Thomas G Pottanat (TG)

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA; Department of Biology, Indiana University - Purdue University Indianapolis, Indianapolis, IN, USA.

Robert W Siegel (RW)

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.

Mariam Ehsani (M)

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.

Yue-Wei Qian (YW)

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.

William C Roell (WC)

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.

Robert J Konrad (RJ)

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: konrad_robert@lilly.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH